0001209191-17-053994.txt : 20170926
0001209191-17-053994.hdr.sgml : 20170926
20170926164633
ACCESSION NUMBER: 0001209191-17-053994
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170925
FILED AS OF DATE: 20170926
DATE AS OF CHANGE: 20170926
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ho Peter Tai-Ching
CENTRAL INDEX KEY: 0001619052
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35945
FILM NUMBER: 171102544
MAIL ADDRESS:
STREET 1: C/O EPIZYME, INC.
STREET 2: 400 TECHNOLOGY SQUARE, 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Epizyme, Inc.
CENTRAL INDEX KEY: 0001571498
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261349956
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-229-5872
MAIL ADDRESS:
STREET 1: 400 TECHNOLOGY SQUARE
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-09-25
0
0001571498
Epizyme, Inc.
EPZM
0001619052
Ho Peter Tai-Ching
C/O EPIZYME, INC.
400 TECHNOLOGY SQUARE
CAMBRIDGE
MA
02139
0
1
0
0
Chief Development Officer
Commons Stock, par value $0.0001
2017-09-25
4
M
0
15000
8.98
A
23123
D
Commons Stock, par value $0.0001
2017-09-25
4
S
0
15000
16.8051
D
8123
D
Common Stock, par value $0.0001
1000
I
By Trust
Common Stock, par value $0.0001
1000
I
By Trust
Stock Option (Right to Buy)
8.98
2017-09-25
4
M
0
15000
0.00
D
2026-02-07
Common Stock
15000
15725
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.70 per share to $17.00 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
These shares are held in a brokerage account jointly owned by the reporting person and his spouse.
These shares are held in trust for the benefit of the reporting person's child. The reporting person's spouse is a trustee of the trust. The reporting person disclaims beneficial ownership of these securities, and the filing is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
The exercise and sale reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
This option is fully vested.
/a/ Adriana Sullivan, attorney-in-fact
2017-09-26